Characteristics of Multi-Organ Lymphangiectasia Resulting from Temporal Deletion of Calcitonin Receptor-Like Receptor in Adult Mice

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Hoopes, Samantha L ^a   Willcockson, Helen H ^a   Caron, Kathleen M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; CALCITONIN RECEPTOR LIKE RECEPTOR; PROTEIN ZO1; TAMOXIFEN; VASCULAR ENDOTHELIAL CADHERIN;

ADM GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCRL GENE; CAPILLARY PERMEABILITY; CONTROLLED STUDY; CORNEA EDEMA; CORNEAL LYMPHANGIECTASIA; DISEASE EXACERBATION; FEMALE; GENE; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE LYMPHANGIECTASIA; INTRACELLULAR SIGNALING; LIPID ABSORPTION; LYMPH NODE HYPERPLASIA; LYMPHANGIECTASIS; MALABSORPTION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PERIPHERAL LYMPHANGIECTASIA; PHARMACOLOGICAL BLOCKING; PROTEIN DEFECT; WEIGHT GAIN; WEIGHT REDUCTION;

ADRENOMEDULLIN; ANIMALS; ANTIGENS, CD; CADHERINS; CALCITONIN RECEPTOR-LIKE PROTEIN; EDEMA; ENDOTHELIAL CELLS; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC VECTORS; INTESTINES; LIMBUS CORNEAE; LYMPHANGIECTASIS; LYMPHATIC VESSELS; MALE; MICE; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; SKIN; TAMOXIFEN; ZONULA OCCLUDENS-1 PROTEIN;

MUS;

EID: 84866455023     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045261     Document Type: Article

References (44)

1. Stacker SA, Farnsworth RH, Karnezis T, Shayan R, Smith DP, et al. (2007) Molecular pathways for lymphangiogenesis and their role in human disease. Novartis Found Symp 281: 38-43; discussion 44-53, 208-209.
2. Stackert RA, Bursik K, (2006) Ego development and the therapeutic goal-setting capacities of mentally ill adults. Am J Psychother 60: 357-374.
3. McColl BK, Paavonen K, Karnezis T, Harris NC, Davydova N, et al. (2007) Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2. FASEB J 21: 1088-1098.
4. Radhakrishnan K, Rockson SG, (2008) The clinical spectrum of lymphatic disease. Ann N Y Acad Sci 1131: 155-184.
5. Rockson SG, (2008) Diagnosis and management of lymphatic vascular disease. J Am Coll Cardiol 52: 799-806.
6. Wen J, Tang Q, Wu J, Wang Y, Cai W, (2010) Primary intestinal lymphangiectasia: four case reports and a review of the literature. Dig Dis Sci 55: 3466-3472.
7. Welch J, Srinivasan S, Lyall D, Roberts F, (2012) Conjunctival lymphangiectasia: a report of 11 cases and review of literature. Surv Ophthalmol 57: 136-148.
8. Manduch M, Oliveira AM, Nascimento AG, Folpe AL, (2009) Massive localised lymphoedema: a clinicopathological study of 22 cases and review of the literature. J Clin Pathol 62: 808-811.
9. Hay DL, Conner AC, Howitt SG, Smith DM, Poyner DR, (2004) The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors. J Mol Neurosci 22: 105-113.
10. Caron KM, Smithies O, (2001) Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. Proc Natl Acad Sci U S A 98: 615-619.
11. Dackor RT, Fritz-Six K, Dunworth WP, Gibbons CL, Smithies O, et al. (2006) Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Mol Cell Biol 26: 2511-2518.
12. Fritz-Six KL, Dunworth WP, Li M, Caron KM, (2008) Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest 118: 40-50.
13. Dackor R, Fritz-Six K, Smithies O, Caron K, (2007) Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age. J Biol Chem 282: 18094-18099.
14. Hippenstiel S, Witzenrath M, Schmeck B, Hocke A, Krisp M, et al. (2002) Adrenomedullin reduces endothelial hyperpermeability. Circ Res 91: 618-625.
15. Kis B, Deli MA, Kobayashi H, Abraham CS, Yanagita T, et al. (2001) Adrenomedullin regulates blood-brain barrier functions in vitro. Neuroreport 12: 4139-4142.
16. Kis B, Snipes JA, Deli MA, Abraham CS, Yamashita H, et al. (2003) Chronic adrenomedullin treatment improves blood-brain barrier function but has no effects on expression of tight junction proteins. Acta Neurochir Suppl 86: 565-568.
17. Dunworth WP, Fritz-Six KL, Caron KM, (2008) Adrenomedullin stabilizes the lymphatic endothelial barrier in vitro and in vivo. Peptides 29: 2243-2249.
18. Petrova TV, Makinen T, Makela TP, Saarela J, Virtanen I, et al. (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. Embo J 21: 4593-4599.
19. Hirakawa S, Hong YK, Harvey N, Schacht V, Matsuda K, et al. (2003) Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 162: 575-586.
20. Wick N, Saharinen P, Saharinen J, Gurnhofer E, Steiner CW, et al. (2007) Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro. Physiol Genomics 28: 179-192.
21. Jin D, Harada K, Ohnishi S, Yamahara K, Kangawa K, et al. (2008) Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema. Cardiovasc Res 80: 339-345.
22. Wang WH, Millar JC, Pang IH, Wax MB, Clark AF, (2005) Noninvasive measurement of rodent intraocular pressure with a rebound tonometer. Invest Ophthalmol Vis Sci 46: 4617-4621.
23. Saeki T, Aihara M, Ohashi M, Araie M, (2008) The efficacy of TonoLab in detecting physiological and pharmacological changes of mouse intraocular pressure-comparison with TonoPen and microneedle manometery. Curr Eye Res 33: 247-252.
24. Sawane M, Kidoya H, Muramatsu F, Takakura N, Kajiya K, (2011) Apelin Attenuates UVB-Induced Edema and Inflammation by Promoting Vessel Function. Am J Pathol 179: 2691-2697.
25. Murakami M, Nguyen LT, Hatanaka K, Schachterle W, Chen PY, et al. (2011) FGF-dependent regulation of VEGF receptor 2 expression in mice. J Clin Invest 121: 2668-2678.
26. Tran M, Forget P, Van den Neucker A, Strik J, van Kreel B, et al. (1994) The acid steatocrit: a much improved method. J Pediatr Gastroenterol Nutr 19: 299-303.
27. Takahashi N, Li F, Hua K, Deng J, Wang CH, et al. (2007) Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab 6: 506-512.
28. Brimnes J, Reimann J, Claesson MH, (2000) Immunoglobulin leakiness in scid mice with CD4(+) T-cell-induced chronic colitis. Clin Immunol 96: 222-229.
29. Ittner LM, Schwerdtfeger K, Kunz TH, Muff R, Husmann K, et al. (2008) Transgenic mice with ocular overexpression of an adrenomedullin receptor reflect human acute angle-closure glaucoma. Clin Sci (Lond) 114: 49-58.
30. Holt PR, (1964) Dietary Treatment of Protein Loss in Intestinal Lymphangiectasia. The Effect of Eliminating Dietary Long Chain Triglycerides on Albumin Metabolism in This Condition. Pediatrics 34: 629-635.
31. Birke K, Lutjen-Drecoll E, Kerjaschki D, Birke MT, (2010) Expression of podoplanin and other lymphatic markers in the human anterior eye segment. Invest Ophthalmol Vis Sci 51: 344-354.
32. Yucel YH, Johnston MG, Ly T, Patel M, Drake B, et al. (2009) Identification of lymphatics in the ciliary body of the human eye: a novel "uveolymphatic" outflow pathway. Exp Eye Res 89: 810-819.
33. Kataoka Y, Miyazaki S, Yasuda S, Nagaya N, Noguchi T, et al. (2010) The first clinical pilot study of intravenous adrenomedullin administration in patients with acute myocardial infarction. J Cardiovasc Pharmacol 56: 413-419.
34. Doods H, Arndt K, Rudolf K, Just S, (2007) CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci 28: 580-587.
35. Salvatore CA, Moore EL, Calamari A, Cook JJ, Michener MS, et al. (2010) Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist. J Pharmacol Exp Ther 333: 152-160.
36. Dixon JB, (2010) Lymphatic lipid transport: sewer or subway? Trends Endocrinol Metab 21: 480-487.
37. Ichikawa-Shindo Y, Sakurai T, Kamiyoshi A, Kawate H, Iinuma N, et al. (2008) The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. J Clin Invest 118: 29-39.
38. Kadmiel M, Fritz-Six K, Pacharne S, Richards GO, Li M, et al. (2011) Research resource: Haploinsufficiency of receptor activity-modifying protein-2 (RAMP2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in mice. Mol Endocrinol 25: 1244-1253.
39. Kahn ML, (2008) Blood is thicker than lymph. J Clin Invest 118: 23-26.
40. Lu JT, Son YJ, Lee J, Jetton TL, Shiota M, et al. (1999) Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development. Mol Cell Neurosci 14: 99-120.
41. Gangula PR, Zhao H, Supowit SC, Wimalawansa SJ, Dipette DJ, et al. (2000) Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. Hypertension 35: 470-475.
42. Zhang L, Hoff AO, Wimalawansa SJ, Cote GJ, Gagel RF, et al. (2001) Arthritic calcitonin/alpha calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity. Pain 89: 265-273.
43. Walker CS, Li X, Whiting L, Glyn-Jones S, Zhang S, et al. (2010) Mice lacking the neuropeptide alpha-calcitonin gene-related peptide are protected against diet-induced obesity. Endocrinology 151: 4257-4269.
44. Cullere X, Shaw SK, Andersson L, Hirahashi J, Luscinskas FW, et al. (2005) Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 105: 1950-1955.